Circulating MicroRNAs in Patients with Psoriasis Treated with Anti-IL-23: A Cohort Study
This study identifies specific circulating miRNAs, including miR-200a-3p, as potential biomarkers for monitoring treatment responses in psoriasis patients. The findings underscore the therapeutic efficacy of risankizumab in modulating miRNA profiles and immune pathways associated with psoriasis pathogenesis. Overall, these results provide new insights into the mechanisms of risankizumab action and highlight miRNAs as promising candidates for personalized medicine approaches in psoriasis management.
Authors
- Ilaria Pace (ORCID: https://orcid.org/0009-0003-7523-1161)
- Manuela Ferracin (ORCID: https://orcid.org/0000-0002-1595-6887)
- Jacopo Sabbatinelli (ORCID: https://orcid.org/0000-0001-9947-6778)
- Massimiliano Bonafè (ORCID: https://orcid.org/0000-0002-5218-6551)
- Anna Campanati (ORCID: https://orcid.org/0000-0002-3740-0839)
- Nadia Viola
- Olivieri Fabiola (ORCID: https://orcid.org/0000-0002-9606-1144)
- Roberta Roncarati (ORCID: https://orcid.org/0000-0002-2371-3316)
- Beatrice Fontana (ORCID: https://orcid.org/0009-0006-8578-3690)
- Giulia Matacchione (ORCID: https://orcid.org/0000-0002-1840-3903)
- Elena Marinelli Busilacchi (ORCID: https://orcid.org/0000-0002-0693-3376)
- Federico Diotallevi (ORCID: https://orcid.org/0000-0003-2274-1742)
Institutions
- Marche Polytechnic University (IT)
- Azienda Ospedaliero Universitaria Ospedali Riuniti (IT)
- Azienda USL di Bologna (IT)
- Istituto di Genetica Molecolare (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Istituto Nazionale di Riposo e Cura per Anziani (IT)
- University of Bologna (IT)
Publication Details
- Journal
- Dermatology and Therapy
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1007/s13555-024-01331-9
- Citations
- 1
- Primary Topic
- Reproductive System and Pregnancy
- Type
- article
- Field-Weighted Citation Impact
- 0.80
Funders
- Università Politecnica delle Marche